Radiation mitigating properties of the lignan component in flaxseed

Wholegrain flaxseed (FS), and its lignan component (FLC) consisting mainly of secoisolariciresinol diglucoside (SDG), have potent lung radioprotective properties while not abrogating the efficacy of radiotherapy. However, while the whole grain was recently shown to also have potent mitigating proper...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cancer 2013-04, Vol.13 (1), p.179-179, Article 179
Hauptverfasser: Pietrofesa, Ralph, Turowski, Jason, Tyagi, Sonia, Dukes, Floyd, Arguiri, Evguenia, Busch, Theresa M, Gallagher-Colombo, Shannon M, Solomides, Charalambos C, Cengel, Keith A, Christofidou-Solomidou, Melpo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 179
container_issue 1
container_start_page 179
container_title BMC cancer
container_volume 13
creator Pietrofesa, Ralph
Turowski, Jason
Tyagi, Sonia
Dukes, Floyd
Arguiri, Evguenia
Busch, Theresa M
Gallagher-Colombo, Shannon M
Solomides, Charalambos C
Cengel, Keith A
Christofidou-Solomidou, Melpo
description Wholegrain flaxseed (FS), and its lignan component (FLC) consisting mainly of secoisolariciresinol diglucoside (SDG), have potent lung radioprotective properties while not abrogating the efficacy of radiotherapy. However, while the whole grain was recently shown to also have potent mitigating properties in a thoracic radiation pneumonopathy model, the bioactive component in the grain responsible for the mitigation of lung damage was never identified. Lungs may be exposed to radiation therapeutically for thoracic malignancies or incidentally following detonation of a radiological dispersion device. This could potentially lead to pulmonary inflammation, oxidative tissue injury, and fibrosis. This study aimed to evaluate the radiation mitigating effects of FLC in a mouse model of radiation pneumonopathy. We evaluated FLC-supplemented diets containing SDG lignan levels comparable to those in 10% and 20% whole grain diets. 10% or 20% FLC diets as compared to an isocaloric control diet (0% FLC) were given to mice (C57/BL6) (n=15-30 mice/group) at 24, 48, or 72-hours after single-dose (13.5 Gy) thoracic x-ray treatment (XRT). Mice were evaluated 4 months post-XRT for blood oxygenation, lung inflammation, fibrosis, cytokine and oxidative damage levels, and survival. FLC significantly mitigated radiation-related animal death. Specifically, mice fed 0% FLC demonstrated 36.7% survival 4 months post-XRT compared to 60-73.3% survival in mice fed 10%-20% FLC initiated 24-72 hours post-XRT. FLC also mitigated radiation-induced lung fibrosis whereby 10% FLC initiated 24-hours post-XRT significantly decreased fibrosis as compared to mice fed control diet while the corresponding TGF-beta1 levels detected immunohistochemically were also decreased. Additionally, 10-20% FLC initiated at any time point post radiation exposure, mitigated radiation-induced lung injury evidenced by decreased bronchoalveolar lavage (BAL) protein and inflammatory cytokine/chemokine release at 16 weeks post-XRT. Importantly, neutrophilic and overall inflammatory cell infiltrate in airways and levels of nitrotyrosine and malondialdehyde (protein and lipid oxidation, respectively) were also mitigated by the lignan diet. Dietary FLC given early post-XRT mitigated radiation effects by decreasing inflammation, lung injury and eventual fibrosis while improving survival. FLC may be a useful agent, mitigating adverse effects of radiation in individuals exposed to incidental radiation, inhaled radioisotopes o
doi_str_mv 10.1186/1471-2407-13-179
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3636021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534612354</galeid><sourcerecordid>A534612354</sourcerecordid><originalsourceid>FETCH-LOGICAL-b543t-431498c7fb122a5e8d0d56112ab0870b41fb6d0e89413608efad74ddcd454b13</originalsourceid><addsrcrecordid>eNp1kt1LwzAUxYMoOqfvPklB8K2a26RN9yLI8AsGguw9pE3aZbRJTTrR_96UzbmBPuWSe_Lj3HOD0AXgG4A8uwXKIE4oZjGQGNjkAI22V4c79Qk69X6JMbAc58foJCFpyhJgIzR9E1KLXlsTtbrXdShNHXXOdsr1WvnIVlG_UFGjayNMVNq2s0aZPtImqhrx6ZWSZ-ioEo1X55tzjOaPD_Ppczx7fXqZ3s_iIqWkjykBOslLVhWQJCJVucQyzQASUeCc4YJCVWQSq3xCgWQ4V5WQjEpZSprSAsgY3a2x3apolSyDCyca3jndCvfFrdB8v2P0gtf2g5Ms4JIBMF0DCm3_Aex3wrR8yJAPGXIgPEQcKFcbG86-r5Tv-dKunAmDBwVlGcOY4F9VLRrFtalsIJat9iW_TwnNIKyABtX1jmqhRNMvvG1Wwz78vhCvhaWz3jtVbV0D5sNX-Mvn5W5c2wc_uyffgQKtqw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1347670030</pqid></control><display><type>article</type><title>Radiation mitigating properties of the lignan component in flaxseed</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Pietrofesa, Ralph ; Turowski, Jason ; Tyagi, Sonia ; Dukes, Floyd ; Arguiri, Evguenia ; Busch, Theresa M ; Gallagher-Colombo, Shannon M ; Solomides, Charalambos C ; Cengel, Keith A ; Christofidou-Solomidou, Melpo</creator><creatorcontrib>Pietrofesa, Ralph ; Turowski, Jason ; Tyagi, Sonia ; Dukes, Floyd ; Arguiri, Evguenia ; Busch, Theresa M ; Gallagher-Colombo, Shannon M ; Solomides, Charalambos C ; Cengel, Keith A ; Christofidou-Solomidou, Melpo</creatorcontrib><description>Wholegrain flaxseed (FS), and its lignan component (FLC) consisting mainly of secoisolariciresinol diglucoside (SDG), have potent lung radioprotective properties while not abrogating the efficacy of radiotherapy. However, while the whole grain was recently shown to also have potent mitigating properties in a thoracic radiation pneumonopathy model, the bioactive component in the grain responsible for the mitigation of lung damage was never identified. Lungs may be exposed to radiation therapeutically for thoracic malignancies or incidentally following detonation of a radiological dispersion device. This could potentially lead to pulmonary inflammation, oxidative tissue injury, and fibrosis. This study aimed to evaluate the radiation mitigating effects of FLC in a mouse model of radiation pneumonopathy. We evaluated FLC-supplemented diets containing SDG lignan levels comparable to those in 10% and 20% whole grain diets. 10% or 20% FLC diets as compared to an isocaloric control diet (0% FLC) were given to mice (C57/BL6) (n=15-30 mice/group) at 24, 48, or 72-hours after single-dose (13.5 Gy) thoracic x-ray treatment (XRT). Mice were evaluated 4 months post-XRT for blood oxygenation, lung inflammation, fibrosis, cytokine and oxidative damage levels, and survival. FLC significantly mitigated radiation-related animal death. Specifically, mice fed 0% FLC demonstrated 36.7% survival 4 months post-XRT compared to 60-73.3% survival in mice fed 10%-20% FLC initiated 24-72 hours post-XRT. FLC also mitigated radiation-induced lung fibrosis whereby 10% FLC initiated 24-hours post-XRT significantly decreased fibrosis as compared to mice fed control diet while the corresponding TGF-beta1 levels detected immunohistochemically were also decreased. Additionally, 10-20% FLC initiated at any time point post radiation exposure, mitigated radiation-induced lung injury evidenced by decreased bronchoalveolar lavage (BAL) protein and inflammatory cytokine/chemokine release at 16 weeks post-XRT. Importantly, neutrophilic and overall inflammatory cell infiltrate in airways and levels of nitrotyrosine and malondialdehyde (protein and lipid oxidation, respectively) were also mitigated by the lignan diet. Dietary FLC given early post-XRT mitigated radiation effects by decreasing inflammation, lung injury and eventual fibrosis while improving survival. FLC may be a useful agent, mitigating adverse effects of radiation in individuals exposed to incidental radiation, inhaled radioisotopes or even after the initiation of radiation therapy to treat malignancy.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/1471-2407-13-179</identifier><identifier>PMID: 23557217</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject><![CDATA[Analysis ; Animal Feed ; Animals ; Bronchoalveolar Lavage Fluid ; Butylene Glycols - administration & dosage ; Cytokines - metabolism ; Drug dosages ; Experiments ; Female ; Fibrosis - etiology ; Fibrosis - prevention & control ; Flax ; Flaxseed ; Glucosides - administration & dosage ; Grain ; Ionizing radiation ; Isoflavones ; Kaplan-Meier Estimate ; Lignans - administration & dosage ; Lung - metabolism ; Lung - pathology ; Lung - radiation effects ; Lung diseases ; Lung Injury - complications ; Lung Injury - metabolism ; Lung Injury - prevention & control ; Lungs ; Malondialdehyde - metabolism ; Mice ; Mice, Inbred C57BL ; Neutrophils ; Oxygen - blood ; Physiological aspects ; Phytotherapy ; Radiation ; Radiation Injuries, Experimental - complications ; Radiation Injuries, Experimental - metabolism ; Radiation Injuries, Experimental - prevention & control ; Radiation Pneumonitis - etiology ; Radiation Pneumonitis - pathology ; Radiation-Protective Agents - administration & dosage ; Radiotherapy ; Seeds ; Survival Rate ; Terrorism ; Time Factors ; Toxicity ; Transforming Growth Factor beta1 - metabolism ; Tyrosine - analogs & derivatives ; Tyrosine - metabolism ; X-rays]]></subject><ispartof>BMC cancer, 2013-04, Vol.13 (1), p.179-179, Article 179</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>2013 Pietrofesa et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Pietrofesa et al.; licensee BioMed Central Ltd. 2013 Pietrofesa et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b543t-431498c7fb122a5e8d0d56112ab0870b41fb6d0e89413608efad74ddcd454b13</citedby><cites>FETCH-LOGICAL-b543t-431498c7fb122a5e8d0d56112ab0870b41fb6d0e89413608efad74ddcd454b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636021/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636021/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23557217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pietrofesa, Ralph</creatorcontrib><creatorcontrib>Turowski, Jason</creatorcontrib><creatorcontrib>Tyagi, Sonia</creatorcontrib><creatorcontrib>Dukes, Floyd</creatorcontrib><creatorcontrib>Arguiri, Evguenia</creatorcontrib><creatorcontrib>Busch, Theresa M</creatorcontrib><creatorcontrib>Gallagher-Colombo, Shannon M</creatorcontrib><creatorcontrib>Solomides, Charalambos C</creatorcontrib><creatorcontrib>Cengel, Keith A</creatorcontrib><creatorcontrib>Christofidou-Solomidou, Melpo</creatorcontrib><title>Radiation mitigating properties of the lignan component in flaxseed</title><title>BMC cancer</title><addtitle>BMC Cancer</addtitle><description>Wholegrain flaxseed (FS), and its lignan component (FLC) consisting mainly of secoisolariciresinol diglucoside (SDG), have potent lung radioprotective properties while not abrogating the efficacy of radiotherapy. However, while the whole grain was recently shown to also have potent mitigating properties in a thoracic radiation pneumonopathy model, the bioactive component in the grain responsible for the mitigation of lung damage was never identified. Lungs may be exposed to radiation therapeutically for thoracic malignancies or incidentally following detonation of a radiological dispersion device. This could potentially lead to pulmonary inflammation, oxidative tissue injury, and fibrosis. This study aimed to evaluate the radiation mitigating effects of FLC in a mouse model of radiation pneumonopathy. We evaluated FLC-supplemented diets containing SDG lignan levels comparable to those in 10% and 20% whole grain diets. 10% or 20% FLC diets as compared to an isocaloric control diet (0% FLC) were given to mice (C57/BL6) (n=15-30 mice/group) at 24, 48, or 72-hours after single-dose (13.5 Gy) thoracic x-ray treatment (XRT). Mice were evaluated 4 months post-XRT for blood oxygenation, lung inflammation, fibrosis, cytokine and oxidative damage levels, and survival. FLC significantly mitigated radiation-related animal death. Specifically, mice fed 0% FLC demonstrated 36.7% survival 4 months post-XRT compared to 60-73.3% survival in mice fed 10%-20% FLC initiated 24-72 hours post-XRT. FLC also mitigated radiation-induced lung fibrosis whereby 10% FLC initiated 24-hours post-XRT significantly decreased fibrosis as compared to mice fed control diet while the corresponding TGF-beta1 levels detected immunohistochemically were also decreased. Additionally, 10-20% FLC initiated at any time point post radiation exposure, mitigated radiation-induced lung injury evidenced by decreased bronchoalveolar lavage (BAL) protein and inflammatory cytokine/chemokine release at 16 weeks post-XRT. Importantly, neutrophilic and overall inflammatory cell infiltrate in airways and levels of nitrotyrosine and malondialdehyde (protein and lipid oxidation, respectively) were also mitigated by the lignan diet. Dietary FLC given early post-XRT mitigated radiation effects by decreasing inflammation, lung injury and eventual fibrosis while improving survival. FLC may be a useful agent, mitigating adverse effects of radiation in individuals exposed to incidental radiation, inhaled radioisotopes or even after the initiation of radiation therapy to treat malignancy.</description><subject>Analysis</subject><subject>Animal Feed</subject><subject>Animals</subject><subject>Bronchoalveolar Lavage Fluid</subject><subject>Butylene Glycols - administration &amp; dosage</subject><subject>Cytokines - metabolism</subject><subject>Drug dosages</subject><subject>Experiments</subject><subject>Female</subject><subject>Fibrosis - etiology</subject><subject>Fibrosis - prevention &amp; control</subject><subject>Flax</subject><subject>Flaxseed</subject><subject>Glucosides - administration &amp; dosage</subject><subject>Grain</subject><subject>Ionizing radiation</subject><subject>Isoflavones</subject><subject>Kaplan-Meier Estimate</subject><subject>Lignans - administration &amp; dosage</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Lung - radiation effects</subject><subject>Lung diseases</subject><subject>Lung Injury - complications</subject><subject>Lung Injury - metabolism</subject><subject>Lung Injury - prevention &amp; control</subject><subject>Lungs</subject><subject>Malondialdehyde - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Neutrophils</subject><subject>Oxygen - blood</subject><subject>Physiological aspects</subject><subject>Phytotherapy</subject><subject>Radiation</subject><subject>Radiation Injuries, Experimental - complications</subject><subject>Radiation Injuries, Experimental - metabolism</subject><subject>Radiation Injuries, Experimental - prevention &amp; control</subject><subject>Radiation Pneumonitis - etiology</subject><subject>Radiation Pneumonitis - pathology</subject><subject>Radiation-Protective Agents - administration &amp; dosage</subject><subject>Radiotherapy</subject><subject>Seeds</subject><subject>Survival Rate</subject><subject>Terrorism</subject><subject>Time Factors</subject><subject>Toxicity</subject><subject>Transforming Growth Factor beta1 - metabolism</subject><subject>Tyrosine - analogs &amp; derivatives</subject><subject>Tyrosine - metabolism</subject><subject>X-rays</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kt1LwzAUxYMoOqfvPklB8K2a26RN9yLI8AsGguw9pE3aZbRJTTrR_96UzbmBPuWSe_Lj3HOD0AXgG4A8uwXKIE4oZjGQGNjkAI22V4c79Qk69X6JMbAc58foJCFpyhJgIzR9E1KLXlsTtbrXdShNHXXOdsr1WvnIVlG_UFGjayNMVNq2s0aZPtImqhrx6ZWSZ-ioEo1X55tzjOaPD_Ppczx7fXqZ3s_iIqWkjykBOslLVhWQJCJVucQyzQASUeCc4YJCVWQSq3xCgWQ4V5WQjEpZSprSAsgY3a2x3apolSyDCyca3jndCvfFrdB8v2P0gtf2g5Ms4JIBMF0DCm3_Aex3wrR8yJAPGXIgPEQcKFcbG86-r5Tv-dKunAmDBwVlGcOY4F9VLRrFtalsIJat9iW_TwnNIKyABtX1jmqhRNMvvG1Wwz78vhCvhaWz3jtVbV0D5sNX-Mvn5W5c2wc_uyffgQKtqw</recordid><startdate>20130404</startdate><enddate>20130404</enddate><creator>Pietrofesa, Ralph</creator><creator>Turowski, Jason</creator><creator>Tyagi, Sonia</creator><creator>Dukes, Floyd</creator><creator>Arguiri, Evguenia</creator><creator>Busch, Theresa M</creator><creator>Gallagher-Colombo, Shannon M</creator><creator>Solomides, Charalambos C</creator><creator>Cengel, Keith A</creator><creator>Christofidou-Solomidou, Melpo</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20130404</creationdate><title>Radiation mitigating properties of the lignan component in flaxseed</title><author>Pietrofesa, Ralph ; Turowski, Jason ; Tyagi, Sonia ; Dukes, Floyd ; Arguiri, Evguenia ; Busch, Theresa M ; Gallagher-Colombo, Shannon M ; Solomides, Charalambos C ; Cengel, Keith A ; Christofidou-Solomidou, Melpo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b543t-431498c7fb122a5e8d0d56112ab0870b41fb6d0e89413608efad74ddcd454b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analysis</topic><topic>Animal Feed</topic><topic>Animals</topic><topic>Bronchoalveolar Lavage Fluid</topic><topic>Butylene Glycols - administration &amp; dosage</topic><topic>Cytokines - metabolism</topic><topic>Drug dosages</topic><topic>Experiments</topic><topic>Female</topic><topic>Fibrosis - etiology</topic><topic>Fibrosis - prevention &amp; control</topic><topic>Flax</topic><topic>Flaxseed</topic><topic>Glucosides - administration &amp; dosage</topic><topic>Grain</topic><topic>Ionizing radiation</topic><topic>Isoflavones</topic><topic>Kaplan-Meier Estimate</topic><topic>Lignans - administration &amp; dosage</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Lung - radiation effects</topic><topic>Lung diseases</topic><topic>Lung Injury - complications</topic><topic>Lung Injury - metabolism</topic><topic>Lung Injury - prevention &amp; control</topic><topic>Lungs</topic><topic>Malondialdehyde - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Neutrophils</topic><topic>Oxygen - blood</topic><topic>Physiological aspects</topic><topic>Phytotherapy</topic><topic>Radiation</topic><topic>Radiation Injuries, Experimental - complications</topic><topic>Radiation Injuries, Experimental - metabolism</topic><topic>Radiation Injuries, Experimental - prevention &amp; control</topic><topic>Radiation Pneumonitis - etiology</topic><topic>Radiation Pneumonitis - pathology</topic><topic>Radiation-Protective Agents - administration &amp; dosage</topic><topic>Radiotherapy</topic><topic>Seeds</topic><topic>Survival Rate</topic><topic>Terrorism</topic><topic>Time Factors</topic><topic>Toxicity</topic><topic>Transforming Growth Factor beta1 - metabolism</topic><topic>Tyrosine - analogs &amp; derivatives</topic><topic>Tyrosine - metabolism</topic><topic>X-rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pietrofesa, Ralph</creatorcontrib><creatorcontrib>Turowski, Jason</creatorcontrib><creatorcontrib>Tyagi, Sonia</creatorcontrib><creatorcontrib>Dukes, Floyd</creatorcontrib><creatorcontrib>Arguiri, Evguenia</creatorcontrib><creatorcontrib>Busch, Theresa M</creatorcontrib><creatorcontrib>Gallagher-Colombo, Shannon M</creatorcontrib><creatorcontrib>Solomides, Charalambos C</creatorcontrib><creatorcontrib>Cengel, Keith A</creatorcontrib><creatorcontrib>Christofidou-Solomidou, Melpo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pietrofesa, Ralph</au><au>Turowski, Jason</au><au>Tyagi, Sonia</au><au>Dukes, Floyd</au><au>Arguiri, Evguenia</au><au>Busch, Theresa M</au><au>Gallagher-Colombo, Shannon M</au><au>Solomides, Charalambos C</au><au>Cengel, Keith A</au><au>Christofidou-Solomidou, Melpo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiation mitigating properties of the lignan component in flaxseed</atitle><jtitle>BMC cancer</jtitle><addtitle>BMC Cancer</addtitle><date>2013-04-04</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>179</spage><epage>179</epage><pages>179-179</pages><artnum>179</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>Wholegrain flaxseed (FS), and its lignan component (FLC) consisting mainly of secoisolariciresinol diglucoside (SDG), have potent lung radioprotective properties while not abrogating the efficacy of radiotherapy. However, while the whole grain was recently shown to also have potent mitigating properties in a thoracic radiation pneumonopathy model, the bioactive component in the grain responsible for the mitigation of lung damage was never identified. Lungs may be exposed to radiation therapeutically for thoracic malignancies or incidentally following detonation of a radiological dispersion device. This could potentially lead to pulmonary inflammation, oxidative tissue injury, and fibrosis. This study aimed to evaluate the radiation mitigating effects of FLC in a mouse model of radiation pneumonopathy. We evaluated FLC-supplemented diets containing SDG lignan levels comparable to those in 10% and 20% whole grain diets. 10% or 20% FLC diets as compared to an isocaloric control diet (0% FLC) were given to mice (C57/BL6) (n=15-30 mice/group) at 24, 48, or 72-hours after single-dose (13.5 Gy) thoracic x-ray treatment (XRT). Mice were evaluated 4 months post-XRT for blood oxygenation, lung inflammation, fibrosis, cytokine and oxidative damage levels, and survival. FLC significantly mitigated radiation-related animal death. Specifically, mice fed 0% FLC demonstrated 36.7% survival 4 months post-XRT compared to 60-73.3% survival in mice fed 10%-20% FLC initiated 24-72 hours post-XRT. FLC also mitigated radiation-induced lung fibrosis whereby 10% FLC initiated 24-hours post-XRT significantly decreased fibrosis as compared to mice fed control diet while the corresponding TGF-beta1 levels detected immunohistochemically were also decreased. Additionally, 10-20% FLC initiated at any time point post radiation exposure, mitigated radiation-induced lung injury evidenced by decreased bronchoalveolar lavage (BAL) protein and inflammatory cytokine/chemokine release at 16 weeks post-XRT. Importantly, neutrophilic and overall inflammatory cell infiltrate in airways and levels of nitrotyrosine and malondialdehyde (protein and lipid oxidation, respectively) were also mitigated by the lignan diet. Dietary FLC given early post-XRT mitigated radiation effects by decreasing inflammation, lung injury and eventual fibrosis while improving survival. FLC may be a useful agent, mitigating adverse effects of radiation in individuals exposed to incidental radiation, inhaled radioisotopes or even after the initiation of radiation therapy to treat malignancy.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>23557217</pmid><doi>10.1186/1471-2407-13-179</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2407
ispartof BMC cancer, 2013-04, Vol.13 (1), p.179-179, Article 179
issn 1471-2407
1471-2407
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3636021
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Analysis
Animal Feed
Animals
Bronchoalveolar Lavage Fluid
Butylene Glycols - administration & dosage
Cytokines - metabolism
Drug dosages
Experiments
Female
Fibrosis - etiology
Fibrosis - prevention & control
Flax
Flaxseed
Glucosides - administration & dosage
Grain
Ionizing radiation
Isoflavones
Kaplan-Meier Estimate
Lignans - administration & dosage
Lung - metabolism
Lung - pathology
Lung - radiation effects
Lung diseases
Lung Injury - complications
Lung Injury - metabolism
Lung Injury - prevention & control
Lungs
Malondialdehyde - metabolism
Mice
Mice, Inbred C57BL
Neutrophils
Oxygen - blood
Physiological aspects
Phytotherapy
Radiation
Radiation Injuries, Experimental - complications
Radiation Injuries, Experimental - metabolism
Radiation Injuries, Experimental - prevention & control
Radiation Pneumonitis - etiology
Radiation Pneumonitis - pathology
Radiation-Protective Agents - administration & dosage
Radiotherapy
Seeds
Survival Rate
Terrorism
Time Factors
Toxicity
Transforming Growth Factor beta1 - metabolism
Tyrosine - analogs & derivatives
Tyrosine - metabolism
X-rays
title Radiation mitigating properties of the lignan component in flaxseed
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A27%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiation%20mitigating%20properties%20of%20the%20lignan%20component%20in%20flaxseed&rft.jtitle=BMC%20cancer&rft.au=Pietrofesa,%20Ralph&rft.date=2013-04-04&rft.volume=13&rft.issue=1&rft.spage=179&rft.epage=179&rft.pages=179-179&rft.artnum=179&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/1471-2407-13-179&rft_dat=%3Cgale_pubme%3EA534612354%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1347670030&rft_id=info:pmid/23557217&rft_galeid=A534612354&rfr_iscdi=true